News From The Entire Globe

Category: Medical Leadership

In the medical industry there are many very hard working people all throughout the various aspects of the field of medicine. Some of the least thought of are those physicians and surgeons that practice plastic surgery. One of the most outstanding within the field of cosmetic surgery is Sam Jejurikar.

There are approximately 100 million medical patients in America that use websites that give them a forum to provide feedback on their physicians. Only the highest rated physicians in both their bedside manner as well as overall performance are awarded the Compassionate Doctor certification and Dr. Jejurikar is a recipient of this honor, one that only 3% of the almost 900,000 physicians active in America will receive.

Dr. Sam Jejurikar is currently an active physician with the Pine Creek Medical Center as well as the Dallas Plastic Surgery Institute. Dr. Jejurikar focuses his expertise on the eyes, nose, mouth, face, body and breast augmentation. He was educated at the University of Michigan Medical School in addition to also doing his residency at the University of Michigan Hospitals and Health Centers.

Dr. Jejurikar is one of the rare plastic surgeons that really cares about his patients and holds a true passion for his work and his ability to help patients achieve their desires, from simply appearing more youthful to completely changing the appearance, his attention to detail and compassion allow him to always give his patients the very best results.

Not only does he help his patients locally, Dr. Sameer Jejurikar is able to use his skills as a brilliant surgeon to help those less fortunate. He has been a participating member of many missions in addition to an annual trip to Bangladesh to help impoverished children there get the proper medical care they need with the help of the organization Smile Bangladesh.

JeanMarie Guenot is leading the fight against the current cancer epidemic. Cancer is one of the leading causes of deaths and treatment options available today simply aren’t able to do much about the prognosis of most cases. Guenot is changing all of this with her work at Amphivena Therapeutics. Here she is helping to advance our understanding of blood cancer and create better treatments for blood cancer. Recently Amphivena announced an entirely new line of blood cancer treatments.

Where Everything Goes From Here

Blood cancer is fairly unique among cancers in that it does not result in obvious masses that doctors can simply target and take out. It is the result of excessive cell growth and the resulting symptoms. JeanMarie Guenot’s approach to blood cancer changes everything by going after blood cancer in a way that works with the body’s immune system and encourages the body to fight back. As a result the patients suffer fewer symptoms while experiencing a superior level of treatment.

The Impact Of Amphivena Therapeutics

Amphivena Therapeutics has introduced a class of antibody therapy drugs into the cancer treatment market. These drugs offer a way to treat blood cancer using the body’s own immune system without any of the dangers commonly seen in chemotherapy. Traditional chemotherapy often destroys the immune system of the patient in hopes of destroying the cancer along with it. This results in many patients suffering from issues ranging from baldness to opportunistic infections. None of this is a concern with Amphivena’s drugs and that is attracting attention. Investors around the world are interested in inveisting in this company.

About JeanMarie Guenot

JeanMarie Guenot is a prominent researcher and entrepreneur with a focus on cancer. She has spent much of her life developing and promoting new treatments for cancer. She struck gold when she developed innovative antibody therapy options for blood cancer and decided to base Amphivena Therapeutics around that idea. Even today she continues to devote herself to researching and developing new drugs to treat some of the world’s most dangerous diseases. Follow along with her career on Dr. Guenot’s Facebook.